切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2023, Vol. 17 ›› Issue (03) : 140 -145. doi: 10.3877/cma.j.issn.1674-3903.2023.03.003

论著

新型冠状病毒感染疫情期间肾移植受者免疫抑制剂服药依从性研究
刘路浩, 苏泳鑫, 曾丽娟, 张鹏, 陈荣鑫, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正()   
  1. 510260 广州医科大学附属第二医院器官移植科
  • 收稿日期:2023-01-31 出版日期:2023-06-25
  • 通信作者: 陈正
  • 基金资助:
    广州医科大学临床重点专科项目基金(010004001); 广州市基础与应用基础研究项目(202102020417); 广东省医学科研基金项目(A2021384); 广州市泌尿疾病学重点学科建设项目(2021-2023)

Drug compliance of immunosuppressant in kidney transplant recipients during the COVID-19 pandemic

Luhao Liu, Yongxin Su, Lijuan Zeng, Peng Zhang, Rongxin Chen, Lu Xu, Guanghui Li, Jiali Fang, Junjie Ma, Zheng Chen()   

  1. Department of organ transplantation, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China
  • Received:2023-01-31 Published:2023-06-25
  • Corresponding author: Zheng Chen
引用本文:

刘路浩, 苏泳鑫, 曾丽娟, 张鹏, 陈荣鑫, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正. 新型冠状病毒感染疫情期间肾移植受者免疫抑制剂服药依从性研究[J]. 中华移植杂志(电子版), 2023, 17(03): 140-145.

Luhao Liu, Yongxin Su, Lijuan Zeng, Peng Zhang, Rongxin Chen, Lu Xu, Guanghui Li, Jiali Fang, Junjie Ma, Zheng Chen. Drug compliance of immunosuppressant in kidney transplant recipients during the COVID-19 pandemic[J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(03): 140-145.

目的

对新型冠状病毒感染(COVID-19)疫情期间肾移植受者服药依从性现状进行调查,并分析其影响因素。

方法

采用方便抽样法选取2021年6月至12月在广州医科大学附属第二医院器官移植科门诊随访中心进行随访的540例肾移植受者作为研究对象。采用一般资料调查表、对COVID-19和新冠疫苗认识程度的调查问卷和免疫抑制剂服药依从性调查问卷进行问卷调查。全部问卷回收后及时进行整理分析,剔除无效问卷。根据免疫抑制剂服药依从性情况将受者分为依从性高组和依从性低组。组间正态分布计量资料采用成组t检验进行比较,计数资料采用χ2检验进行比较。P<0.05为差异有统计学意义。

结果

本研究共发放调查问卷540份,剔除无效问卷29份,回收有效问卷511份,回收有效率94.6%(511/540)。511例受者中403例(78.9%)表示对COVID-19疫情存在担心,但450例(88.1%)受者表示自己不会发生COVID-19,目前有5例(1.0%)受者发生过COVID-19。260例(50.9%)受者表示愿意接种新冠疫苗,486例(95.1%)会选择接种灭活疫苗;414例(81.0%)受者最担心出现排斥反应。511例受者过去1个月内,忘记服用抗排斥反应药物1次及以上受者203例(39.7%);连续2次或多次忘记服用抗排斥反应药物的受者16例(3.1%);提前或延迟2 h服药的受者213例(41.7%);自行调整抗排斥反应药物剂量的受者12例(2.3%)。225例(44.0%)受者主要因个人因素导致漏服或自行停用抗排斥反应药物,87例(17.0%)表示因工作繁忙而导致错误服药,因疫情导致无法出门购药只有8例(1.6%)。511例受者中247例受者纳入依从性高组,余264例受者纳入依从性低组。两组受者教育状况及最近1次复查血清肌酐水平差异有统计学意义(χ2=117.12,t=-6.48,P均<0.05)。

结论

肾移植受者术后服药依从性仍有待提高,其服药依从性可能与文化程度有关,应采取相应的干预措施提高受者服药依从性。

Objective

To investigate the current status of drug compliance of immunosuppressant and analyze its influencing factors in kidney transplant recipients during the COVID-19 pandemic.

Methods

540 renal transplant recipients who were followed up in the outpatient clinic in the Organ Transplantation Center of the Second Affiliated Hospital of Guangzhou Medical University, from June 2021 to December 2021, were selected by the convenience sampling method to do the questionnaire. Surveys on general information, COVID-19 and COVID-19 vaccine, and drug compliance of immunosuppressant were conducted in renal transplant recipients. All the questionnaires were promptly organized and analyzed after collection, and then the invalid questionnaires were excluded. The recipients were divided into high drug compliance group and low drug compliance group according to drug compliance of immunoswppressant. The measurement data of normal distribution between groups were compared by group t test. Chi-squared test was used to compare the counting data. P<0.05 indicates a statistically significant difference.

Results

A total of 540 survey questionnaires were distributed in this study, with 29 invalid questionnaires excluded. A total of 511 valid questionnaires were collected, with a recovery effectiveness rate of 94.6% (511/540). Among 511 recipients, 403 recipients (78.9%) expressed concern about the COVID-19 pandemic, but 450 recipients (88.1%) stated that they would not experience COVID-19. Only 5 (1.0%) recipients had experienced COVID-19. 260 (50.9%) recipients were willing to receive COVID-19 vaccine, and 486 recipients (95.1%) would choose to receive inactivated vaccine, 414 recipients (81.0%) were most concerned about acute rejection for vaccination. For 511 recipients in the past month, 203 recipients (39.7%) forgot to take immunosuppressive medication once or more; 16 recipients (3.1%) forgot to take immunosuppressive medication twice or multiple times; 213 recipients (41.7%) received immunosuppressive medication early or delayed for 2 hours; 12 recipients (2.3%) adjusted the dosage of immunosuppressive medication on their own. 225 recipients (44.0%) forgot or stopped taking the anti-rejection drugs due to personal factors. 87 recipients (17.0%) reported taking medication incorrectly due to busy work schedules. Only 8 recipients (1.6%) were unable to go out to purchase medication due to the COVID-19 pandemic. Among 511 recipients, 247 recipients were included in high drug compliance group and 264 recipients were included in low drug compliance group. There were significant differences between the two groups in terms of educational level and serum creatinine level for recent time (χ2=117.12, t=-6.48, all P<0.05).

Conclusions

The drug compliance of kidney transplant recipients remains to be improved, and the education status may be related to the drug compliance of immunosuppressant of kidney transplant recipients. Corresponding intervention measures should be taken to improve the drug compliance.

表1 纳入调查的511例肾移植受者一般资料
表2 纳入调查的511例肾移植受者对COVID-19和新冠疫苗认识程度的调查结果
表3 纳入调查的511例肾移植受者免疫抑制剂服药依从性BAASIS量表各条目水平[例(%)]
表4 免疫抑制剂服药依从性高和依从性低组肾移植受者一般资料比较
1
Li CJ, Li L. Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use[J]. Drug Des Devel Ther, 20159:473-485.
2
Manickavasagar R, Wong G, Alexander SI, et al. Allograft outcome following repeat transplantation of patients with non-adherence-related first kidney allograft failure: a population cohort study[J]. Transpl Int, 201932(12):1247-1258.
3
Wang Y, Veltkamp D, van der Boog P, et al. Illness perceptions and medication nonadherence to immunosuppressants after successful kidney transplantation: a cross-sectional study[J]. Transpl Int, 202235:10073.
4
Zhang P, Zhu X, Yan J, et al. Identification of immunosuppressive medication nonadherence factors through a combined theory model in renal transplant recipients: 6-12[J]. Front Pharmacol, 202112:655836.
5
Kobayashi S, Tsutsui J, Okabe S, et al. Medication nonadherence after kidney transplantation: an internet-based survey in Japan[J]. Psychol Health Med, 202025(1):91-101.
6
贾丽燕,景懿磊,张千,等. 新型冠状病毒肺炎暴发期间肝移植受者服药依从性与生命质量调查研究[J]. 肝脏202126(6):655-660.
7
Cheung CY, Chan KM, Tang G, et al. Immunosuppressive medication adherence in kidney transplant recipients during the COVID-19 pandemic: a cross-sectional study in Hong Kong[J]. Transplant Proc, 202153(8):2447-2450.
8
王振迪,夏秋翔,曾宪鹏,等. 公众对异种移植态度的问卷调查分析[J]. 中华器官移植杂志202243(9):536-543.
9
沈如芬,沈鸣雁,曾静,等. 居家肾移植受者新型冠状病毒肺炎知信行调查及影响因素分析[J/CD]. 中华移植杂志:电子版202014(6):373-377.
10
Dobbels F, Berben L, De Geest S, et al. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review[J]. Transplantation, 201090(2):205-219.
11
Nerini E, Bruno F, Citterio F, et al. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?[J]. J Nephrol, 201629(5):627-636.
12
Demian MN, Shapiro RJ, Thornton WL. An observational study of health literacy and medication adherence in adult kidney transplant recipients[J]. Clin Kidney J, 20169(6):858-865.
13
De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss transplant cohort study[J]. Transpl Int, 201427(7):657-666.
14
林俊,丁小明,朱一辰,等. 肾移植受者新型冠状病毒疫苗接种建议[J]. 中华器官移植杂志202243(2):67-73.
15
中华医学会器官移植学分会. 新型冠状病毒肺炎疫情期间全国器官捐献与移植工作的指导原则(二○二○年二月二十三日通过)[J]. 器官移植202011(2):179-184.
16
Prihodova L, Nagyova I, Rosenberger J, et al. Social participation after kidney transplantation as a predictor of graft loss and mortality over 10 years: a longitudinal study[J]. Transplantation, 201599(3):568-575.
17
Weng LC, Yang YC, Huang HL, et al. Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: a correlational study[J]. J Adv Nurs, 201773(1):228-239.
18
Huuskes BM, Scholes-Robertson N, Guha C, et al. Kidney transplant recipient perspectives on telehealth during the COVID-19 pandemic[J]. Transpl Int, 202134(8):1517-1529.
19
Duivenvoorden R, Vart P, Noordzij M, et al. Clinical, functional, and mental health outcomes in kidney transplant recipients 3 months after a diagnosis of COVID-19[J]. Transplantation, 2022106(5):1012-1023.
[1] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[2] 李安琪, 徐祎琳, 向天新. 新型冠状病毒感染后肺纤维化病变诊治进展[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 294-298.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[4] 彭雨诗, 苗芸, 严紫嫣. 宏基因组高通量测序诊断肾移植术后华支睾吸虫感染一例[J]. 中华移植杂志(电子版), 2023, 17(05): 297-299.
[5] 彭文翰. 肾移植受者早期霉酚酸强化剂量长期有效性和安全性的研究[J]. 中华移植杂志(电子版), 2023, 17(05): 0-.
[6] 胡皓翀, 刘一霆, 郭嘉瑜, 邹寄林, 陈忠宝, 周江桥, 邱涛. 肾移植术后耐碳青霉烯类肺炎克雷伯菌感染的诊疗分析[J]. 中华移植杂志(电子版), 2023, 17(04): 246-249.
[7] 戚若晨, 马帅军, 韩士超, 王国辉, 刘克普, 张小燕, 杨晓剑, 秦卫军. 肾移植术后新型冠状病毒感染单中心诊疗经验[J]. 中华移植杂志(电子版), 2023, 17(04): 232-239.
[8] 巨春蓉, 何建行, 钟南山. 咪唑立宾在器官移植领域的应用及展望[J]. 中华移植杂志(电子版), 2023, 17(04): 227-231.
[9] 朱伟芳, 陈琳, 乔建军. 激光联合光动力疗法治疗肾移植后鲍恩样丘疹病一例[J]. 中华移植杂志(电子版), 2023, 17(04): 250-252.
[10] 吴建永. 单中心2 000例心脏死亡器官捐献肾移植发展与创新[J]. 中华移植杂志(电子版), 2023, 17(04): 0-.
[11] 中国康复医学会器官移植康复专业委员会. 成人实体器官移植后糖尿病管理专家共识[J]. 中华移植杂志(电子版), 2023, 17(04): 205-220.
[12] 徐烨, 李婧, 刘冉佳, 潘晨, 郭明星, 崔向丽. 2017至2021年中国95家医疗机构肝移植术后免疫抑制剂用药分析[J]. 中华移植杂志(电子版), 2023, 17(03): 134-139.
[13] 王红敏, 谢云波, 王彦虎, 王福生. 间充质干细胞治疗新冠病毒感染的临床研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 247-256.
[14] 李金璞, 饶向荣. 抗病毒药物和急性肾损伤[J]. 中华肾病研究电子杂志, 2023, 12(05): 287-290.
[15] 田丹阳, 刘小璇, 叶珊, 马新然, 樊东升, 傅瑜. 新型冠状病毒感染疫情对神经内科住院医师规范化培训的影响[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 499-504.
阅读次数
全文


摘要